Clinical Trial Update: Sirolimus to Treat Cowden Syndrome and Other PTEN Hamartomatous Tumor Syndromes [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated sirolimus for Cowden syndrome and related PTEN hamartoma tumor syndromes and has completed with results posted in 2013. The study was …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cowden Syndrome
• Pten Hamartoma Tumor Syndrome

Drugs mentioned

• Rapamune (sirolimus)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Cowden's Disease, Hamartoma Syndrome, Multiple | Phase 2 | Status: COMPLETED | Results posted: 2013-07-19